Speciality Chemicals Stocks in India
Speciality Chemicals: Pidilite Industries Ltd owns the largest revenue base; Fineotex Chemical Ltd has the fastest current growth.
Nifty Speciality Chemicals Index — Constituents & Performance
The Speciality Chemicals companies below are the listed Indian Speciality Chemicals universe this page tracks — the same constituent set people search for as the Nifty Speciality Chemicals index. Every figure is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.
How has Speciality Chemicals moved against NIFTY 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 23% ahead of NIFTY 500. Earnings across its companies grew 9% on average over the last four reported quarters. It has been ahead of NIFTY 500 on a rolling three-month view for 18 weeks running.
RS ↑18w · 21/28 >200d (+1) · 15/28 lead (−3) · EPS 23/28↑
Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 28 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
Is Speciality Chemicals outperforming NIFTY 500?
Speciality Chemicals has outperformed NIFTY 500 by 13.8% over the last 52 weeks. Over 13 weeks the gap is a lead of 19.3%. 20 of 28 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Aether Industries Ltd is the strongest against the sector itself at +30.3%. Readings are as of 2026-08-09.
Sector metric: 39.4 as of 2026-08-09 · LEADERS · rising.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
Speciality Chemicals has outperformed NIFTY 500 by 13.8% over 52 weeks and 19.3% over 13 weeks. 20 of 28 covered companies beat NIFTY on Mansfield relative strength, while 7 of 25 beat the sector itself. Pidilite Industries Ltd leads with revenue of ₹15,399 crore, based on 28 of 28 comparable companies through Jun 2026.
Best Speciality Chemicals Stocks in India (Aug 2026), Ranked by Data
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
How this score is built, and what the marks mean
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Top 10 Speciality Chemicals Stocks in India
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Panama Petrochem LtdPANAMAPET | 77.4/100Favorable setup100% evidence | LEADER | 28.0/35 Revenue 45.9% · PAT 100% · OPM change 14 pp 100% evidence | 14.9/25 ROCE 19.2% · OPM 22% 100% evidence | 15.5/20 P/E 6.1× · PEG 0.55 100% evidence | 19.0/20 RS sector 25.9% · RS bench 48% · 1Y 38%12 of 12 weeks ahead 100% evidence |
| Exact sum: 28 + 14.9 + 15.5 + 19 = 77.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Sunshield Chemicals Ltd530845 | 71.3/100Favorable setup76% evidence | BREAKING OUT | 29.6/35 Revenue 20.5% · PAT 100% · OPM change 5 pp 95% evidence | 16.6/25 ROCE 19.9% · OPM 16% 76% evidence | 11.2/20 P/E 30.5× · PEG — 50% evidence | 13.9/20 RS sector 2.6% · RS bench 27.8% · 1Y 41.1%11 of 11 weeks ahead 70% evidence |
| Exact sum: 29.6 + 16.6 + 11.2 + 13.9 = 71.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3Vikram Thermo (India) Ltd530477 | 64.4/100Mixed-positive evidence67% evidence | BREAKING OUT | 24.0/35 Revenue 7% · PAT 100% · OPM change 8 pp 95% evidence | 19.8/25 ROCE 36.4% · OPM 48% 76% evidence | 8.2/20 P/E 20.8× · PEG — 50% evidence | 12.4/20 RS sector — · RS bench 61% · 1Y —6 of 6 weeks ahead 25% evidence |
| Exact sum: 24 + 19.8 + 8.2 + 12.4 = 64.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 4Black Rose Industries LtdBLACKROSE | 63.6/100Mixed-positive evidence72% evidence | TURNING | 22.2/35 Revenue 8.6% · PAT 28.6% · OPM change 6 pp 95% evidence | 17.1/25 ROCE 18.9% · OPM 16% 95% evidence | 13.8/20 P/E 18.6× · PEG — 50% evidence | 10.5/20 RS sector — · RS bench 6.4% · 1Y —1 of 2 weeks ahead 25% evidence |
| Exact sum: 22.2 + 17.1 + 13.8 + 10.5 = 63.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Yasho Industries LtdYASHO | 62.9/100Mixed-positive evidence87% evidence | BREAKING OUT | 29.2/35 Revenue 34.1% · PAT 100% · OPM change 7 pp 100% evidence | 8.6/25 ROCE 8.9% · OPM 24% 100% evidence | 12.0/20 P/E 88.1× · PEG 1.15 65% evidence | 13.1/20 RS sector -2% · RS bench 118% · 1Y 140.7%11 of 11 weeks ahead 70% evidence |
| Exact sum: 29.2 + 8.6 + 12 + 13.1 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Privi Speciality Chemicals LtdPRIVISCL | 60.9/100Mixed-positive evidence75% evidence | TURNING | 24.8/35 Revenue 21.6% · PAT 62.1% · OPM change -1 pp 95% evidence | 17.9/25 ROCE 22.3% · OPM 23% 76% evidence | 9.5/20 P/E 38.9× · PEG — 15% evidence | 8.7/20 RS sector -5.1% · RS bench 12.5% · 1Y 42.6%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24.8 + 17.9 + 9.5 + 8.7 = 60.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Pidilite Industries LtdPIDILITIND | 60.0/100Mixed-positive evidence100% evidence | BREAKING OUT | 22.6/35 Revenue 14.1% · PAT 21.5% · OPM change 1 pp 100% evidence | 20.6/25 ROCE 31% · OPM 26% 100% evidence | 7.4/20 P/E 65.1× · PEG 3.8 100% evidence | 9.4/20 RS sector -5.8% · RS bench 11.7% · 1Y 9.9%10 of 12 weeks ahead 100% evidence |
| Exact sum: 22.6 + 20.6 + 7.4 + 9.4 = 60 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Aether Industries LtdAETHER | 58.4/100Mixed-positive evidence100% evidence | BREAKING OUT | 24.4/35 Revenue 34.4% · PAT 34.3% · OPM change -1 pp 100% evidence | 10.7/25 ROCE 11.9% · OPM 31% 100% evidence | 4.1/20 P/E 89.9× · PEG 8.9 100% evidence | 19.2/20 RS sector 30.3% · RS bench 54.1% · 1Y 121.4%10 of 12 weeks ahead 100% evidence |
| Exact sum: 24.4 + 10.7 + 4.1 + 19.2 = 58.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Tatva Chintan Pharma Chem LtdTATVA | 57.2/100Mixed-positive evidence93% evidence | BREAKING OUT | 30.2/35 Revenue 41.1% · PAT 100% · OPM change 4 pp 100% evidence | 6.5/25 ROCE 7.1% · OPM 19% 100% evidence | 4.7/20 P/E 76.7× · PEG 5.63 65% evidence | 15.8/20 RS sector 11.4% · RS bench 32% · 1Y 64.8%7 of 12 weeks ahead 100% evidence |
| Exact sum: 30.2 + 6.5 + 4.7 + 15.8 = 57.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Aarti Industries LtdAARTIIND | 56.8/100Mixed-positive evidence100% evidence | TURNING | 27.6/35 Revenue 27% · PAT 100% · OPM change 3 pp 100% evidence | 8.3/25 ROCE 6.8% · OPM 16% 100% evidence | 8.0/20 P/E 37.1× · PEG 2.05 100% evidence | 12.9/20 RS sector 4.4% · RS bench 23.7% · 1Y 42.4%5 of 12 weeks ahead 100% evidence |
| Exact sum: 27.6 + 8.3 + 8 + 12.9 = 56.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Fineotex Chemical LtdFCL | 53.4/100Mixed-positive evidence100% evidence | LEADER | 18.4/35 Revenue 91.5% · PAT 41% · OPM change -2 pp 100% evidence | 12.7/25 ROCE 18.3% · OPM 16% 100% evidence | 3.2/20 P/E 41.3× · PEG 4.19 100% evidence | 19.1/20 RS sector 29.6% · RS bench 51.9% · 1Y 84%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 12.7 + 3.2 + 19.1 = 53.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12DMCC Speciality Chemicals LtdDMCC | 53.3/100Mixed-positive evidence80% evidence | BASING | 24.2/35 Revenue 49.7% · PAT 42.9% · OPM change 0 pp 95% evidence | 11.2/25 ROCE 15.3% · OPM 13% 95% evidence | 11.3/20 P/E 18.4× · PEG — 15% evidence | 6.6/20 RS sector -8.3% · RS bench 8.5% · 1Y -12.3%6 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 11.2 + 11.3 + 6.6 = 53.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.3% and the one-year return is -12.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 13Kronox Lab Sciences LtdKRONOX | 52.2/100Mixed-positive evidence65% evidence | TURNING | 9.4/35 Revenue 6.1% · PAT 11.6% · OPM change -1.1 pp 95% evidence | 21.6/25 ROCE 36% · OPM 31.7% 95% evidence | 10.9/20 P/E 19.6× · PEG — 15% evidence | 10.3/20 RS sector — · RS bench 4.5% · 1Y —1 of 1 week ahead 25% evidence |
| Exact sum: 9.4 + 21.6 + 10.9 + 10.3 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Chemcon Speciality Chemicals LtdCHEMCON | 49.2/100Mixed-negative evidence81% evidence | BREAKING OUT | 21.0/35 Revenue 16.7% · PAT 12% · OPM change 8 pp 95% evidence | 10.7/25 ROCE 6.4% · OPM 23% 95% evidence | 12.0/20 P/E 24.8× · PEG — 50% evidence | 5.5/20 RS sector -21.5% · RS bench -3.9% · 1Y -16.2%9 of 10 weeks ahead 70% evidence |
| Exact sum: 21 + 10.7 + 12 + 5.5 = 49.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Alkyl Amines Chemicals LtdALKYLAMINE | 47.8/100Mixed-negative evidence97% evidence | BREAKING OUT | 18.3/35 Revenue 5.1% · PAT 21% · OPM change 6 pp 95% evidence | 15.4/25 ROCE 16.6% · OPM 25% 95% evidence | 5.0/20 P/E 43.5× · PEG 5.37 100% evidence | 9.1/20 RS sector -6.3% · RS bench 10.5% · 1Y -7.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 15.4 + 5 + 9.1 = 47.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Galaxy Surfactants LtdGALAXYSURF | 47.0/100Mixed-negative evidence94% evidence | BREAKING OUT | 19.5/35 Revenue 27% · PAT 15.7% · OPM change 4 pp 100% evidence | 9.4/25 ROCE 13.5% · OPM 14% 100% evidence | 8.9/20 P/E 24.5× · PEG 4.39 100% evidence | 9.2/20 RS sector -11.9% · RS bench 23.3% · 1Y 2.8%5 of 10 weeks ahead 70% evidence |
| Exact sum: 19.5 + 9.4 + 8.9 + 9.2 = 47 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Vinati Organics LtdVINATIORGA | 44.8/100Mixed-negative evidence82% evidence | ASLEEP | 11.2/35 Revenue 5.1% · PAT 5.7% · OPM change -5 pp 95% evidence | 17.5/25 ROCE 19.8% · OPM 24% 76% evidence | 13.3/20 P/E 30.9× · PEG — 50% evidence | 2.8/20 RS sector -25.6% · RS bench -11.4% · 1Y -19.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.2 + 17.5 + 13.3 + 2.8 = 44.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 18Neogen Chemicals LtdNEOGEN | 43.5/100Mixed-negative evidence90% evidence | LEADER | 14.6/35 Revenue 18.1% · PAT 6.1% · OPM change 2 pp 100% evidence | 6.7/25 ROCE 6.5% · OPM 19% 100% evidence | 5.1/20 P/E 170× · PEG — 50% evidence | 17.1/20 RS sector 20.9% · RS bench 42.1% · 1Y 55.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 14.6 + 6.7 + 5.1 + 17.1 = 43.5 · Decision use: Price leads the evidence: RS versus the benchmark is 42.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 19Amal Ltd506597 | 41.9/100Mixed-negative evidence69% evidence | BREAKING OUT | 8.0/35 Revenue 79% · PAT -23.1% · OPM change -7 pp 95% evidence | 16.4/25 ROCE 26% · OPM 18% 76% evidence | 9.9/20 P/E 31× · PEG — 15% evidence | 7.6/20 RS sector -23.2% · RS bench 11.7% · 1Y -24.3%7 of 10 weeks ahead 70% evidence |
| Exact sum: 8 + 16.4 + 9.9 + 7.6 = 41.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Platinum Industries LtdPLATIND | 41.7/100Mixed-negative evidence74% evidence | ASLEEP | 12.9/35 Revenue 9.6% · PAT 6.5% · OPM change -1 pp 95% evidence | 12.3/25 ROCE 15.7% · OPM 12% 95% evidence | 10.7/20 P/E 23.3× · PEG — 15% evidence | 5.8/20 RS sector -10.3% · RS bench -12.8% · 1Y -20.7%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.9 + 12.3 + 10.7 + 5.8 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Anupam Rasayan India LtdANURAS | 41.3/100Mixed-negative evidence82% evidence | ASLEEP | 20.0/35 Revenue 51.7% · PAT 14.8% · OPM change -1 pp 95% evidence | 10.5/25 ROCE 7.4% · OPM 25% 76% evidence | 8.2/20 P/E 78.8× · PEG — 50% evidence | 2.6/20 RS sector -19.6% · RS bench -4.2% · 1Y 7.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 10.5 + 8.2 + 2.6 = 41.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Vishnu Chemicals LtdVISHNU | 40.1/100Mixed-negative evidence100% evidence | TURNING | 15.5/35 Revenue 16.5% · PAT 17.2% · OPM change -1 pp 100% evidence | 11.3/25 ROCE 16.4% · OPM 15% 100% evidence | 6.0/20 P/E 27.4× · PEG 2.82 100% evidence | 7.3/20 RS sector -6.4% · RS bench 10.9% · 1Y 27.7%8 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 11.3 + 6 + 7.3 = 40.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Grauer & Weil (India) LtdGRAUWEIL | 38.2/100Mixed-negative evidence100% evidence | FADING | 10.6/35 Revenue 10.1% · PAT 6.6% · OPM change -5 pp 100% evidence | 16.7/25 ROCE 21.4% · OPM 16% 100% evidence | 8.2/20 P/E 19.1× · PEG 4.01 100% evidence | 2.7/20 RS sector -26.1% · RS bench -12.5% · 1Y -30.1%9 of 12 weeks ahead 100% evidence |
| Exact sum: 10.6 + 16.7 + 8.2 + 2.7 = 38.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Amines & Plasticizers LtdAMNPLST | 37.4/100Mixed-negative evidence81% evidence | ASLEEP | 7.8/35 Revenue -12.4% · PAT -3% · OPM change 0.7 pp 95% evidence | 14.0/25 ROCE 16.7% · OPM 9.9% 95% evidence | 8.5/20 P/E 27.5× · PEG — 50% evidence | 7.1/20 RS sector -19.2% · RS bench 0.5% · 1Y -7.2%9 of 10 weeks ahead 70% evidence |
| Exact sum: 7.8 + 14 + 8.5 + 7.1 = 37.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Paushak LtdPAUSHAKLTD | 37.1/100Mixed-negative evidence81% evidence | BREAKING OUT | 11.9/35 Revenue 15.4% · PAT -15.7% · OPM change -1 pp 95% evidence | 10.0/25 ROCE 8.3% · OPM 31% 95% evidence | 7.9/20 P/E 43.1× · PEG — 50% evidence | 7.3/20 RS sector -27.3% · RS bench 25.8% · 1Y -0.7%8 of 11 weeks ahead 70% evidence |
| Exact sum: 11.9 + 10 + 7.9 + 7.3 = 37.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Clean Science & Technology LtdCLEAN | 35.4/100Mixed-negative evidence94% evidence | TURNING | 4.5/35 Revenue -0.4% · PAT -13.8% · OPM change -5 pp 100% evidence | 18.1/25 ROCE 20.6% · OPM 36% 100% evidence | 8.3/20 P/E 37.5× · PEG 6.24 100% evidence | 4.5/20 RS sector -24.1% · RS bench -7.1% · 1Y -30.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 4.5 + 18.1 + 8.3 + 4.5 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Transpek Industry LtdTRANSPEK | 34.6/100Adverse evidence81% evidence | BASING | 6.4/35 Revenue -5.2% · PAT -29.1% · OPM change -2.3 pp 95% evidence | 9.1/25 ROCE 8.3% · OPM 13.3% 95% evidence | 13.6/20 P/E 16.1× · PEG — 50% evidence | 5.5/20 RS sector -19.5% · RS bench -5.7% · 1Y -24.9%2 of 10 weeks ahead 70% evidence |
| Exact sum: 6.4 + 9.1 + 13.6 + 5.5 = 34.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 28Thirumalai Chemicals LtdTIRUMALCHM | 24.5/100Adverse evidence69% evidence | ASLEEP | 13.1/35 Revenue -5.8% · PAT -36.9% · OPM change 12 pp 71% evidence | 1.1/25 ROCE -3.1% · OPM 6% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 0.3/20 RS sector -39.5% · RS bench -28.1% · 1Y -44.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 1.1 + 10 + 0.3 = 24.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Market action
Yasho Industries Ltd has the strongest one-year price move in Speciality Chemicals at +140.7%. It also leads on Mansfield relative strength against NIFTY at +118%. 20 of 28 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-08-14.
Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
The same measure taken against Speciality Chemicals itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
Speciality Chemicals — the story behind the numbers
This is the written read behind the Speciality Chemicals figures above — what is actually happening in the sector, in words, with the evidence each claim rests on. It is dated 29 Jul 2026. 5 themes are live here, 4 of them rated high severity. It also states what would change this read.
The sector exhibits solid balance sheet health but uneven operational performance. Operating leverage inflection is driving profit growth for most, yet commodity volatility remains a persistent headwind. Capital allocation is focused on capacity expansion among larger players. Investors should monitor raw material trajectories and regulatory compliance costs.
The Speciality Chemicals sector displays divergent performance in Q4 FY26. 5 of 7 constituents reported positive PAT YoY growth, ranging from 21.45% to 109.05%. However, 2 constituents reported profit declines, including Amal Ltd which saw PAT collapse 71.98% despite 94.4% revenue growth.
How old this read is: This read comes from our Speciality Chemicals sector brief dated 29 Jul 2026, so the words here and the numbers above them cover the same few weeks.
What is live in this sector right now
| Live theme | Severity | Evidence on file |
|---|---|---|
| All 7 constituents reported raw material price volatility impacting margins.Named for 506597, 530477, 530845, GRAUWEIL | high | “Sulphur accounts for ~50% of cost structure with significant price volatility; Q4 FY26 PAT collapsed 71.98% despite 94.40% revenue growth due to raw material inflation.” Panama Petrochem mitigates risk by passing on significant cost increases to customers with monthly/quarterly price adjustment provisions. |
| All 7 constituents face regulatory compliance risks including pollution norms and licensing.Named for 506597, 530477, 530845, GRAUWEIL | high | “Phosgene manufacturing license is highly restricted by the government, creating operational dependency.” Paushak Ltd plants are equipped with automated protection systems for hazardous gas manufacturing. |
| 4 constituents reported active litigation including customs penalties and mall closure disputes.Named for 506597, 530845, GRAUWEIL, KRONOX | high | “Customs penalty order received October 2024 with penalty of Rs. 4,94,90,488 and Redemption Fine of Rs. 2,56,12,547” Sunshield Chemicals believes there is a strong case of merit and law regarding customs penalty. |
| 2 constituents reported labor risks including worker death and cost increases.Named for 530477, KRONOX | high | Kronox Lab Sciences stated police deployed heavy security and officials assured impartial probe. |
| 3 constituents cited geopolitical tensions influencing supply chains or export markets.Named for 530845, KRONOX, PANAMAPET | medium | “Directors Report FY25-26 cites geopolitical tensions, trade disputes, and evolving tariff structures influencing supply chains and commodity markets” Panama Petrochem noted geographically diversified revenue across 75+ countries. |
What would change this read
A quarterly print showing sustained Chinese dumping that permanently rebases specialty margins downwards or failure of the newly commercialized battery materials and CDMO capacities to scale.
Sources: our Speciality Chemicals sector brief, 29 Jul 2026 · company earnings-call transcripts.
Revenue Scale & Growth Durability
Pidilite Industries Ltd has the highest Revenue among the 28 Speciality Chemicals companies compared here, at ₹15,399 crore. Aarti Industries Ltd is next at ₹9,010 crore. Fineotex Chemical Ltd has the highest Revenue growth at 91.5%, so level and change sit with different companies. 28 of 28 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Pidilite Industries Ltd is the scale leader at ₹15,399 crore, 70.9% ahead of Aarti Industries Ltd. Fineotex Chemical Ltd's growth is 91.5% from a ₹1,013 crore base, with 20 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
Investor read: Pidilite Industries Ltd is the scale benchmark; Fineotex Chemical Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: Pidilite Industries Ltd's growth falls below Fineotex Chemical Ltd's for two consecutive comparable reports while operating margin also compresses.
On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| Pidilite Industries Ltd PIDILITIND | ₹4.6K Cr | 21% | Jun 2026 |
| Aarti Industries Ltd AARTIIND | ₹2.4K Cr | 43% | Jun 2026 |
| Galaxy Surfactants Ltd GALAXYSURF | ₹1.8K Cr | 39% | Jun 2026 |
| Panama Petrochem Ltd PANAMAPET | ₹1.7K Cr | 150% | Jun 2026 |
| Vinati Organics Ltd VINATIORGA | ₹696 Cr | 28% | Jun 2026 |
| Privi Speciality Chemicals Ltd PRIVISCL | ₹666 Cr | 19% | Jun 2026 |
| Anupam Rasayan India Ltd ANURAS | ₹655 Cr | 35% | Jun 2026 |
| Thirumalai Chemicals Ltd TIRUMALCHM⚠ unverified | ₹547 Cr | 22% | Jun 2026 |
| Alkyl Amines Chemicals Ltd ALKYLAMINE | ₹528 Cr | 30% | Jun 2026 |
| Vishnu Chemicals Ltd VISHNU | ₹433 Cr | 25% | Jun 2026 |
| Fineotex Chemical Ltd FCL | ₹377 Cr | 175% | Jun 2026 |
| Aether Industries Ltd AETHER | ₹327 Cr | 27% | Jun 2026 |
| Yasho Industries Ltd YASHO | ₹308 Cr | 55% | Jun 2026 |
| Grauer & Weil (India) Ltd GRAUWEIL | ₹299 Cr | 18% | Jun 2026 |
| Clean Science & Technology Ltd CLEAN | ₹268 Cr | 10% | Jun 2026 |
| DMCC Speciality Chemicals Ltd DMCC⚠ unverified | ₹253 Cr | 99% | Jun 2026 |
| Neogen Chemicals Ltd NEOGEN | ₹250 Cr | 34% | Jun 2026 |
| Tatva Chintan Pharma Chem Ltd TATVA | ₹167 Cr | 43% | Jun 2026 |
| Transpek Industry Ltd TRANSPEK | ₹151 Cr | -2.1% | Jun 2026 |
| Amines & Plasticizers Ltd AMNPLST⚠ unverified | ₹151 Cr | 7.3% | Jun 2026 |
| Sunshield Chemicals Ltd 530845 | ₹127 Cr | 11% | Jun 2026 |
| Platinum Industries Ltd PLATIND⚠ unverified | ₹109 Cr | -5.2% | Jun 2026 |
| Amal Ltd 506597 | ₹97 Cr | 106% | Jun 2026 |
| Black Rose Industries Ltd BLACKROSE | ₹89 Cr | 48% | Jun 2026 |
| Paushak Ltd PAUSHAKLTD⚠ unverified | ₹84 Cr | 50% | Jun 2026 |
| Chemcon Speciality Chemicals Ltd CHEMCON⚠ unverified | ₹66 Cr | 22% | Jun 2026 |
| Vikram Thermo (India) Ltd 530477 | ₹38 Cr | 31% | Jun 2026 |
| Kronox Lab Sciences Ltd KRONOX | ₹28 Cr | 17% | Jun 2026 |
Full 20-quarter history · every available company
Revenue · reported quarter history
Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Anupam Rasayan India Ltd · ANURAS
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Privi Speciality Chemicals Ltd · PRIVISCL
Vinati Organics Ltd · VINATIORGA
Yasho Industries Ltd · YASHO
Revenue growth · reported quarter history
Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Anupam Rasayan India Ltd · ANURAS
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Privi Speciality Chemicals Ltd · PRIVISCL
Vinati Organics Ltd · VINATIORGA
Yasho Industries Ltd · YASHO
Operating Economics & Margin Trend
Vikram Thermo (India) Ltd has the highest OPM among the 28 Speciality Chemicals companies compared here, at 48%. Clean Science & Technology Ltd is next at 36%. Panama Petrochem Ltd has the highest Margin change at +14 percentage points, so level and change sit with different companies. 28 of 28 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Vikram Thermo (India) Ltd leads opm at 48%; Panama Petrochem Ltd leads margin change at +14 percentage points.
Investor read: Vikram Thermo (India) Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
All-company data · latest reported quarter
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| Vikram Thermo (India) Ltd 530477 | 48% | +8.0 pp | Jun 2026 |
| Clean Science & Technology Ltd CLEAN | 36% | −5.0 pp | Jun 2026 |
| Kronox Lab Sciences Ltd KRONOX | 32% | −1.1 pp | Jun 2026 |
| Aether Industries Ltd AETHER | 31% | −1.0 pp | Jun 2026 |
| Paushak Ltd PAUSHAKLTD⚠ unverified | 31% | −1.0 pp | Jun 2026 |
| Pidilite Industries Ltd PIDILITIND | 26% | +1.0 pp | Jun 2026 |
| Anupam Rasayan India Ltd ANURAS | 25% | −1.0 pp | Jun 2026 |
| Alkyl Amines Chemicals Ltd ALKYLAMINE | 25% | +6.0 pp | Jun 2026 |
| Vinati Organics Ltd VINATIORGA | 24% | −5.0 pp | Jun 2026 |
| Yasho Industries Ltd YASHO | 24% | +7.0 pp | Jun 2026 |
| Privi Speciality Chemicals Ltd PRIVISCL | 23% | −1.0 pp | Jun 2026 |
| Chemcon Speciality Chemicals Ltd CHEMCON⚠ unverified | 23% | +8.0 pp | Jun 2026 |
| Panama Petrochem Ltd PANAMAPET | 22% | +14.0 pp | Jun 2026 |
| Neogen Chemicals Ltd NEOGEN | 19% | +2.0 pp | Jun 2026 |
| Tatva Chintan Pharma Chem Ltd TATVA | 19% | +4.0 pp | Jun 2026 |
| Amal Ltd 506597 | 18% | −7.0 pp | Jun 2026 |
| Sunshield Chemicals Ltd 530845 | 16% | +5.0 pp | Jun 2026 |
| Aarti Industries Ltd AARTIIND | 16% | +3.0 pp | Jun 2026 |
| Fineotex Chemical Ltd FCL | 16% | −2.0 pp | Jun 2026 |
| Grauer & Weil (India) Ltd GRAUWEIL | 16% | −5.0 pp | Jun 2026 |
| Black Rose Industries Ltd BLACKROSE | 16% | +6.0 pp | Jun 2026 |
| Vishnu Chemicals Ltd VISHNU | 15% | −1.0 pp | Jun 2026 |
| Galaxy Surfactants Ltd GALAXYSURF | 14% | +4.0 pp | Jun 2026 |
| Transpek Industry Ltd TRANSPEK | 13% | −2.3 pp | Jun 2026 |
| DMCC Speciality Chemicals Ltd DMCC⚠ unverified | 13% | 0.0 pp | Jun 2026 |
| Platinum Industries Ltd PLATIND⚠ unverified | 12% | −1.0 pp | Jun 2026 |
| Amines & Plasticizers Ltd AMNPLST⚠ unverified | 9.9% | +0.7 pp | Jun 2026 |
| Thirumalai Chemicals Ltd TIRUMALCHM⚠ unverified | 6.0% | +12.0 pp | Jun 2026 |
Full 20-quarter history · every available company
OPM · reported quarter history
Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Anupam Rasayan India Ltd · ANURAS
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Privi Speciality Chemicals Ltd · PRIVISCL
Vinati Organics Ltd · VINATIORGA
Yasho Industries Ltd · YASHO
Margin change · reported quarter history
Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Anupam Rasayan India Ltd · ANURAS
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Privi Speciality Chemicals Ltd · PRIVISCL
Vinati Organics Ltd · VINATIORGA
Yasho Industries Ltd · YASHO
Profit Scale & Acceleration
Pidilite Industries Ltd has the highest Net profit among the 28 Speciality Chemicals companies compared here, at ₹2,677 crore. Aarti Industries Ltd is next at ₹531 crore. Vikram Thermo (India) Ltd has the highest Profit growth at the 100% top of the scoring scale, so level and change sit with different companies.
What the numbers say: Pidilite Industries Ltd leads with ₹2,677 crore of TTM profit, 404.1% above Aarti Industries Ltd. Vikram Thermo (India) Ltd shows ≥100% on the scoring scale (446.1% uncapped) growth from a ₹39 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
Investor read: Pidilite Industries Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
All-company data · latest reported quarter
| Company | Net profit | Profit growth | Reported |
|---|---|---|---|
| Pidilite Industries Ltd PIDILITIND | ₹884 Cr | 30% | Jun 2026 |
| Panama Petrochem Ltd PANAMAPET | ₹309 Cr | 619% | Jun 2026 |
| Galaxy Surfactants Ltd GALAXYSURF | ₹166 Cr | 110% | Jun 2026 |
| Aarti Industries Ltd AARTIIND | ₹155 Cr | 260% | Jun 2026 |
| Vinati Organics Ltd VINATIORGA | ₹109 Cr | 4.8% | Jun 2026 |
| Alkyl Amines Chemicals Ltd ALKYLAMINE | ₹95 Cr | 94% | Jun 2026 |
| Privi Speciality Chemicals Ltd PRIVISCL | ₹83 Cr | 43% | Jun 2026 |
| Clean Science & Technology Ltd CLEAN | ₹73 Cr | 4.3% | Jun 2026 |
| Aether Industries Ltd AETHER | ₹63 Cr | 34% | Jun 2026 |
| Anupam Rasayan India Ltd ANURAS | ₹51 Cr | 6.3% | Jun 2026 |
| Fineotex Chemical Ltd FCL | ₹48 Cr | 92% | Jun 2026 |
| Vishnu Chemicals Ltd VISHNU | ₹40 Cr | 25% | Jun 2026 |
| Grauer & Weil (India) Ltd GRAUWEIL | ₹40 Cr | -9.1% | Jun 2026 |
| Yasho Industries Ltd YASHO | ₹36 Cr | 800% | Jun 2026 |
| DMCC Speciality Chemicals Ltd DMCC⚠ unverified | ₹20 Cr | 150% | Jun 2026 |
| Amal Ltd 506597 | ₹17 Cr | 89% | Jun 2026 |
| Neogen Chemicals Ltd NEOGEN | ₹17 Cr | 70% | Jun 2026 |
| Tatva Chintan Pharma Chem Ltd TATVA | ₹16 Cr | 129% | Jun 2026 |
| Paushak Ltd PAUSHAKLTD⚠ unverified | ₹15 Cr | 25% | Jun 2026 |
| Vikram Thermo (India) Ltd 530477 | ₹13 Cr | 63% | Jun 2026 |
| Sunshield Chemicals Ltd 530845 | ₹13 Cr | 86% | Jun 2026 |
| Platinum Industries Ltd PLATIND⚠ unverified | ₹11 Cr | -15% | Jun 2026 |
| Chemcon Speciality Chemicals Ltd CHEMCON⚠ unverified | ₹11 Cr | 83% | Jun 2026 |
| Black Rose Industries Ltd BLACKROSE | ₹10 Cr | 150% | Jun 2026 |
| Amines & Plasticizers Ltd AMNPLST⚠ unverified | ₹9 Cr | 27% | Jun 2026 |
| Transpek Industry Ltd TRANSPEK | ₹9 Cr | -43% | Jun 2026 |
| Kronox Lab Sciences Ltd KRONOX | ₹7 Cr | 16% | Jun 2026 |
| Thirumalai Chemicals Ltd TIRUMALCHM⚠ unverified | ₹-44 Cr | -760% | Jun 2026 |
Full 20-quarter history · every available company
Net profit · reported quarter history
Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Anupam Rasayan India Ltd · ANURAS
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Privi Speciality Chemicals Ltd · PRIVISCL
Vinati Organics Ltd · VINATIORGA
Yasho Industries Ltd · YASHO
Profit growth · reported quarter history
Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Anupam Rasayan India Ltd · ANURAS
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Privi Speciality Chemicals Ltd · PRIVISCL
Vinati Organics Ltd · VINATIORGA
Yasho Industries Ltd · YASHO
Return On Capital Employed
Vikram Thermo (India) Ltd has the highest ROCE among the 28 Speciality Chemicals companies compared here, at 36.4%. Kronox Lab Sciences Ltd is next at 36%. Tatva Chintan Pharma Chem Ltd has the highest ROCE change at +8.3 percentage points, so level and change sit with different companies.
What the numbers say: Vikram Thermo (India) Ltd leads ROCE at 36.4%, 0.4 percentage points above Kronox Lab Sciences Ltd. Tatva Chintan Pharma Chem Ltd has the strongest latest improvement at +8.3 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
Investor read: Vikram Thermo (India) Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
Withheld from this chart: Vinati Organics Ltd (VINATIORGA) — its two data sources disagree by up to 27% on reported income across 14 comparable periods, so its derived ratios are withheld; Anupam Rasayan India Ltd (ANURAS) — its two data sources disagree by up to 63% on reported income across 15 comparable periods, so its derived ratios are withheld; Privi Speciality Chemicals Ltd (PRIVISCL) — its two data sources disagree by up to 5.9% on reported income across 14 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| Pidilite Industries Ltd PIDILITIND | 32% | +2.1 pp | Jun 2026 |
| Panama Petrochem Ltd PANAMAPET | 18% | −1.1 pp | Jun 2026 |
| Amines & Plasticizers Ltd AMNPLST⚠ unverified | 17% | −5.5 pp | Jun 2026 |
| Clean Science & Technology Ltd CLEAN | 17% | −4.8 pp | Jun 2026 |
| DMCC Speciality Chemicals Ltd DMCC⚠ unverified | 17% | +1.4 pp | Jun 2026 |
| Grauer & Weil (India) Ltd GRAUWEIL | 15% | −2.0 pp | Jun 2026 |
| Vishnu Chemicals Ltd VISHNU | 15% | −2.1 pp | Jun 2026 |
| Alkyl Amines Chemicals Ltd ALKYLAMINE | 13% | −1.6 pp | Jun 2026 |
| Fineotex Chemical Ltd FCL | 13% | −3.2 pp | Jun 2026 |
| Galaxy Surfactants Ltd GALAXYSURF | 12% | −2.8 pp | Jun 2026 |
| Platinum Industries Ltd PLATIND⚠ unverified | 12% | −1.6 pp | Jun 2026 |
| Aether Industries Ltd AETHER | 12% | +3.0 pp | Jun 2026 |
| Yasho Industries Ltd YASHO | 11% | +2.6 pp | Jun 2026 |
| Tatva Chintan Pharma Chem Ltd TATVA | 9.7% | +8.3 pp | Jun 2026 |
| Aarti Industries Ltd AARTIIND | 8.4% | +1.0 pp | Jun 2026 |
| Paushak Ltd PAUSHAKLTD⚠ unverified | 6.7% | −1.9 pp | Jun 2026 |
| Neogen Chemicals Ltd NEOGEN | 6.4% | −4.3 pp | Jun 2026 |
| Chemcon Speciality Chemicals Ltd CHEMCON⚠ unverified | 3.8% | −0.6 pp | Jun 2026 |
| Thirumalai Chemicals Ltd TIRUMALCHM⚠ unverified | -3.2% | −2.9 pp | Jun 2026 |
Full 20-quarter history · every available company
ROCE · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Grauer & Weil (India) Ltd · GRAUWEIL
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Tatva Chintan Pharma Chem Ltd · TATVA
Vishnu Chemicals Ltd · VISHNU
Yasho Industries Ltd · YASHO
ROCE change · reported quarter history
Showing the 12 largest of 19 companies with a series here. The remaining 7 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Grauer & Weil (India) Ltd · GRAUWEIL
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Tatva Chintan Pharma Chem Ltd · TATVA
Vishnu Chemicals Ltd · VISHNU
Yasho Industries Ltd · YASHO
Valuation Against Growth & Quality
Panama Petrochem Ltd has the lowest PEG among the 28 Speciality Chemicals companies compared here, at 0.55×. Yasho Industries Ltd is next at 1.15×. The same company also holds the lowest P/E, at 6.1×. 12 of 28 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Panama Petrochem Ltd has the lowest comparable PEG at 0.55×, 52.2% below Yasho Industries Ltd. Only 12 of 28 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
All-company data · latest reported quarter
| Company | PEG | P/E | Reported |
|---|---|---|---|
| Neogen Chemicals Ltd NEOGEN | 14.4 | 172.3 | Jun 2026 |
| Aether Industries Ltd AETHER | 8.9 | 77.7 | Jun 2026 |
| Clean Science & Technology Ltd CLEAN | 6.2 | 36.0 | Jun 2026 |
| Tatva Chintan Pharma Chem Ltd TATVA | 5.6 | 65.7 | Jun 2026 |
| Alkyl Amines Chemicals Ltd ALKYLAMINE | 5.4 | 50.8 | Jun 2026 |
| Galaxy Surfactants Ltd GALAXYSURF | 4.4 | 25.8 | Jun 2026 |
| Fineotex Chemical Ltd FCL | 4.2 | 44.0 | Jun 2026 |
| Grauer & Weil (India) Ltd GRAUWEIL | 4.0 | 20.0 | Jun 2026 |
| Pidilite Industries Ltd PIDILITIND | 3.8 | 66.1 | Jun 2026 |
| Vishnu Chemicals Ltd VISHNU | 2.8 | 28.8 | Jun 2026 |
| Aarti Industries Ltd AARTIIND | 2.1 | 51.4 | Jun 2026 |
| Yasho Industries Ltd YASHO | 1.2 | 137.5 | Jun 2026 |
| Panama Petrochem Ltd PANAMAPET | 0.6 | 11.5 | Jun 2026 |
| Amal Ltd 506597 | — | 32.3 | Jun 2026 |
| Vikram Thermo (India) Ltd 530477 | — | 18.8 | Jun 2026 |
| Sunshield Chemicals Ltd 530845 | — | 34.9 | Jun 2026 |
| Vinati Organics Ltd VINATIORGA | — | 31.9 | Jun 2026 |
| Anupam Rasayan India Ltd ANURAS | — | 85.3 | Jun 2026 |
| Privi Speciality Chemicals Ltd PRIVISCL | — | 42.4 | Jun 2026 |
| Thirumalai Chemicals Ltd TIRUMALCHM⚠ unverified | — | -99.1 | Jun 2026 |
| Paushak Ltd PAUSHAKLTD⚠ unverified | — | 31.0 | Jun 2026 |
| Platinum Industries Ltd PLATIND⚠ unverified | — | 24.3 | Jun 2026 |
| Amines & Plasticizers Ltd AMNPLST⚠ unverified | — | 28.8 | Jun 2026 |
| DMCC Speciality Chemicals Ltd DMCC⚠ unverified | — | 23.7 | Jun 2026 |
| Chemcon Speciality Chemicals Ltd CHEMCON⚠ unverified | — | 28.4 | Jun 2026 |
| Transpek Industry Ltd TRANSPEK | — | 12.5 | Jun 2026 |
| Kronox Lab Sciences Ltd KRONOX | — | 20.6 | Jun 2026 |
| Black Rose Industries Ltd BLACKROSE | — | 28.6 | Jun 2026 |
Full 20-quarter history · every available company
PEG · reported quarter history
Showing the 12 largest of 13 companies with a series here. The remaining 1 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Grauer & Weil (India) Ltd · GRAUWEIL
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Tatva Chintan Pharma Chem Ltd · TATVA
Vishnu Chemicals Ltd · VISHNU
Yasho Industries Ltd · YASHO
P/E · reported quarter history
Showing the 12 largest of 28 companies with a series here. The remaining 16 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Aarti Industries Ltd · AARTIIND
Aether Industries Ltd · AETHER
Alkyl Amines Chemicals Ltd · ALKYLAMINE
Anupam Rasayan India Ltd · ANURAS
Clean Science & Technology Ltd · CLEAN
Fineotex Chemical Ltd · FCL
Galaxy Surfactants Ltd · GALAXYSURF
Neogen Chemicals Ltd · NEOGEN
Pidilite Industries Ltd · PIDILITIND
Privi Speciality Chemicals Ltd · PRIVISCL
Vinati Organics Ltd · VINATIORGA
Yasho Industries Ltd · YASHO
What can make this comparison misleading?
This Speciality Chemicals comparison names 6 specific ways its own evidence can mislead, all listed below. All 28 companies here report on comparable dates, so no rank carries a stale marker. 6 draw at least one figure from a second feed with too little overlap to cross-check. 3 have second-feed figures withheld because the two sources disagree.
Keep these limits visible
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- 6 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
- 3 companies are missing from the second-feed metrics by decision, not by absence: the two sources disagree, so nothing from the second is drawn. Read those rows as narrower evidence, never as a weaker business.
How was this comparison built?
This comparison is built from the reported filings of 28 Speciality Chemicals companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-08-14. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
How a second data feed is admitted, and what happens when it disagrees
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.
Speciality Chemicals company comparison FAQs
These 24 answers restate the Speciality Chemicals comparison above in question form. Every one is computed from the same 28 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-08-14. Nothing here is estimated, and none of it is a recommendation.
Is the Speciality Chemicals sector outperforming NIFTY 500?
Speciality Chemicals has outperformed NIFTY 500 by 13.8% over 52 weeks and 19.3% over 13 weeks. 20 of 28 covered companies beat NIFTY on Mansfield relative strength, while 7 of 25 beat the sector itself.
Which Speciality Chemicals company is largest by revenue?
Pidilite Industries Ltd leads with revenue of ₹15,399 crore, based on 28 of 28 comparable companies through Jun 2026.
Which Speciality Chemicals company is growing fastest?
Fineotex Chemical Ltd has the fastest current revenue growth at 91.5%, across 28 of 28 comparable companies.
Which Speciality Chemicals company has the strongest 4-Factor Sector Score?
Panama Petrochem Ltd ranks first at 77.4/100 with 100% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Speciality Chemicals company has the lowest comparable PEG?
Panama Petrochem Ltd has the lowest comparable PEG at 0.55, among 12 of 28 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this Speciality Chemicals comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
Is there a Nifty Speciality Chemicals index?
NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers Speciality Chemicals, this page builds its own equal-weight basket of 28 listed Speciality Chemicals companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.
Which are the best Speciality Chemicals stocks in India?
Ranked by this page's four-factor score, Panama Petrochem Ltd places first among 28 listed Speciality Chemicals companies, followed by Sunshield Chemicals Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.
How many Speciality Chemicals stocks are listed in India?
This comparison covers 28 listed Speciality Chemicals companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.
Which Speciality Chemicals company is the biggest?
Pidilite Industries Ltd is the largest, with trailing-twelve-month revenue of ₹15,399 crore, ahead of Aarti Industries Ltd at ₹9,010 crore. That covers 28 of 28 companies with comparable reporting through Jun 2026.
Which Speciality Chemicals company has the best profit margins?
Vikram Thermo (India) Ltd has the highest operating margin at 48%, from 28 of 28 comparable companies. Panama Petrochem Ltd shows the biggest recent improvement, at +14 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Speciality Chemicals company makes the most profit?
Pidilite Industries Ltd earns the most, at ₹2,677 crore of trailing-twelve-month net profit, from 28 of 28 comparable companies. Vikram Thermo (India) Ltd has the fastest profit growth at the ≥100% scoring cap, though growth off a small or recovering profit base overstates how much has actually changed.
Which Speciality Chemicals company earns the highest return on capital?
Vikram Thermo (India) Ltd leads on return on capital employed at 36.4%, across 28 of 28 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Speciality Chemicals stock is the cheapest?
On PEG — where a LOWER number is cheaper — Panama Petrochem Ltd screens cheapest at 0.55×. Only 12 of 28 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Is the Speciality Chemicals sector beating the market?
Speciality Chemicals has outperformed NIFTY 500 by 13.8% over the last 52 weeks and 19.3% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 20 of 28 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Speciality Chemicals stock has the strongest price momentum?
Yasho Industries Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Speciality Chemicals company scores highest for research priority?
Panama Petrochem Ltd scores 77.4 out of 100 with 100% evidence confidence, from 28 points on growth and earnings, 14.9 on capital efficiency, 15.5 on valuation and 19 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Speciality Chemicals companies does this comparison cover, and over what period?
It compares 28 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Speciality Chemicals sector?
The 28 Speciality Chemicals companies on this page carry ₹3,24,273 crore of combined market value. Pidilite Industries Ltd is the largest at ₹1,72,312 crore, about 53% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-18.
What is the Speciality Chemicals sector's P/E ratio?
The median price-to-earnings ratio across the 28 Speciality Chemicals companies on this page is 30.9×, measured on the 27 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-08-18.
How is the Speciality Chemicals sector performing?
20 of the 28 covered Speciality Chemicals companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 13.8% ahead of NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-18.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.